Rismocef 1gm/0.5gm Injection
Marketer
Trigenesis Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (1gm) + Sulbactam (0.5gm)
Overview Rismocef 1gm/0.5gm Injection
Cefrimox (1g/0.5g) injection is a dual-action antibiotic used to combat a range of bacterial infections. Its mechanism involves inhibiting microbial growth, thereby controlling infection spread. Administration must always be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is vital, even with symptom improvement, as premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) require urgent medical care. Prior to commencing treatment, inform your physician of all current medications and pre-existing conditions. This is particularly important for pregnant or breastfeeding individuals. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to a swifter recovery. Your doctor may request blood tests and other assessments to monitor treatment response.
Uses of Rismocef 1gm/0.5gm Injection
Infections caused by bacteria
Major Benefits of Rismocef 1gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Rismocef 1gm/0.5gm Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Rismocef 1gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Rismocef 1gm/0.5gm Injection works:
Rismocef Injection, available in 1g and 0.5g strengths, combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Rismocef 1gm/0.5gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Rismocef (1gm/0.5gm) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Rismocef injection (1g/0.5g) to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Rismocef injection (1g or 0.5g) may cause drowsiness, visual disturbances, or dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Rismocef 1gm/0.5gm Injection use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Rismocef 1gm/0.5gm Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Rismocef 1gm/0.5gm Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Rismocef 1gm/0.5gm Injection :
Omit a Rismocef 1gm/0.5gm Injection dose? Seek your physician's advice.
Facts to Know About Rismocef 1gm/0.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective medications |
3,018 People bought this recently